Manufacturers Life Insurance Company, The Erasca, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Erasca, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 67,661 shares of ERAS stock, worth $182,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,661
Previous 47,861
41.37%
Holding current value
$182,684
Previous $112,000
64.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ERAS
# of Institutions
141Shares Held
229MCall Options Held
28.7KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$52.4 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.8MShares$45.4 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$43.8 Million4.58% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$37.2 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$35.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $330M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...